These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17070883)

  • 41. The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization.
    Le May N; Gauliard N; Billecocq A; Bouloy M
    J Virol; 2005 Sep; 79(18):11974-80. PubMed ID: 16140773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental Rift Valley fever in rhesus macaques.
    Peters CJ; Jones D; Trotter R; Donaldson J; White J; Stephen E; Slone TW
    Arch Virol; 1988; 99(1-2):31-44. PubMed ID: 3355374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a Rift Valley fever virus viremia challenge model in sheep and goats.
    Weingartl HM; Miller M; Nfon C; Wilson WC
    Vaccine; 2014 Apr; 32(20):2337-44. PubMed ID: 24631070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation and characterization of a recombinant Rift Valley fever virus expressing a V5 epitope-tagged RNA-dependent RNA polymerase.
    Brennan B; Li P; Elliott RM
    J Gen Virol; 2011 Dec; 92(Pt 12):2906-2913. PubMed ID: 21900422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments.
    Wichgers Schreur PJ; Kortekaas J
    PLoS Pathog; 2016 Aug; 12(8):e1005800. PubMed ID: 27548280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment.
    Suzich JA; Kakach LT; Collett MS
    J Virol; 1990 Apr; 64(4):1549-55. PubMed ID: 2319645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of Toscana and Rift Valley fever virus transcription complexes on heterologous templates.
    Accardi L; Prehaud C; Di Bonito P; Mochi S; Bouloy M; Giorgi C
    J Gen Virol; 2001 Apr; 82(Pt 4):781-785. PubMed ID: 11257182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
    Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient cellular release of Rift Valley fever virus requires genomic RNA.
    Piper ME; Sorenson DR; Gerrard SR
    PLoS One; 2011 Mar; 6(3):e18070. PubMed ID: 21445316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia.
    Bowen MD; Trappier SG; Sanchez AJ; Meyer RF; Goldsmith CS; Zaki SR; Dunster LM; Peters CJ; Ksiazek TG; Nichol ST;
    Virology; 2001 Dec; 291(2):185-90. PubMed ID: 11878887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation.
    Raymond DD; Piper ME; Gerrard SR; Smith JL
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11769-74. PubMed ID: 20547879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.
    Garcia S; Crance JM; Billecocq A; Peinnequin A; Jouan A; Bouloy M; Garin D
    J Clin Microbiol; 2001 Dec; 39(12):4456-61. PubMed ID: 11724861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a sheep challenge model for Rift Valley fever.
    Faburay B; Gaudreault NN; Liu Q; Davis AS; Shivanna V; Sunwoo SY; Lang Y; Morozov I; Ruder M; Drolet B; Scott McVey D; Ma W; Wilson W; Richt JA
    Virology; 2016 Feb; 489():128-40. PubMed ID: 26748334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variability of the NS(S) protein among Rift Valley fever virus isolates.
    Sall AA; de A Zanotto PM; Zeller HG; Digoutte JP; Thiongane Y; Bouloy M
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2853-8. PubMed ID: 9367372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection.
    Narayanan A; Popova T; Turell M; Kidd J; Chertow J; Popov SG; Bailey C; Kashanchi F; Kehn-Hall K
    PLoS One; 2011; 6(5):e20354. PubMed ID: 21655261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae).
    Xu F; Liu D; Nunes MR; DA Rosa AP; Tesh RB; Xiao SY
    Am J Trop Med Hyg; 2007 Jun; 76(6):1194-200. PubMed ID: 17556635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Messenger RNA of the M segment RNA of Rift Valley fever virus.
    Collett MS
    Virology; 1986 May; 151(1):151-6. PubMed ID: 3962188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced pathogenicity associated with a small plaque variant of the Egyptian strain of Rift Valley fever virus (ZH501).
    Moussa MI; Wood OL; Abdel Wahab KS
    Trans R Soc Trop Med Hyg; 1982; 76(4):482-6. PubMed ID: 6926765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bidirectional infection and release of Rift Valley fever virus in polarized epithelial cells.
    Gerrard SR; Rollin PE; Nichol ST
    Virology; 2002 Sep; 301(2):226-35. PubMed ID: 12359425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Rift Valley Fever virus protein NSm and putative cellular protein interactions.
    Engdahl C; Näslund J; Lindgren L; Ahlm C; Bucht G
    Virol J; 2012 Jul; 9():139. PubMed ID: 22838834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.